Servier and Google Cloud Extend AI Partnership to Accelerate Drug R&D

January 16, 2025, Suresnes, France and Sunnyvale, California-The global pharmaceutical leader Servier and Google Cloud have announced their expansion of a five-year partnership with the goal of altering drug research and development by utilizing Artificial Intelligence (AI)and Generative AI technologies. 

This expansion will utilize over 60 AI driven use cases such as managing clinical trials and working on finding therapeutic targets.  

The industry of pharmaceuticals is in dire need of improving as part of the numerous problems that it has is that it can take up to around 15 years to develop a single drug. To work towards resolving this Servier seeks to shorten this time period by using AI.

 This aids in bettering the patient. 

“This partnership enables us to harness AI’s full potential, delivering innovative treatment faster and a solution more tailored to the patient,”

– Servier’s Executive Vice President of R&D, Claude Bertrand.  

The Gemini AI models that are a part of Google Cloud will further aid the Servier researchers by giving them efficient tools for analyzing enormous amounts of data.

This in turn allows quicker identification of promising treatments and therapies. Their goals, however, also include working towards the enhancement of supply chain efficiency, overseeing their environmental impact and secure data management. 

“Servier’s ethical and pragmatic AI use is changing the landscape of healthcare R&D.”

-Shweta Maniar, Global Director of Google Cloud’s Healthcare & Life Sciences Speak.

This partnership further strengthens Servier’s commitment towards the digital changes and innovation in the pharmaceutical industry. With the incorporation of AI into their processes, Servier is set to further enhance their research and development efficiency while complying with strict data privacy requirements.  

The importance of AI in today’s healthcare sector is highlighted, particularly in the novel approaches to drug discovery and development for unaddressed medical issues. Soon new relevant information regarding AI usage will be published as well. Now patients can expect more advanced and affordable treatments while AI enabled healthcare technologies to become more popular globally.

Latest Post

Telstra-Accenture Forge $3B AI Partnership to Revolutionize Telecoms

Capgemini: Gen AI’s Carbon Footprint Sparks Urgent Sustainability Concerns

Microsoft and Pearson Forge Partnership to Tackle AI Skilling Challenges

You can also check our news article: Ericsson and Nokia Demand EU Action to Secure Tech Leadership

Ericsson and Nokia Demand EU Action to Secure Tech Leadership